Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
291
-
Total 13F shares, excl. options
-
111,608,181
-
Shares change
-
-3,902,593
-
Total reported value, excl. options
-
$2,000,687,993
-
Value change
-
-$67,870,563
-
Put/Call ratio
-
120%
-
Number of buys
-
106
-
Number of sells
-
-135
-
Price
-
$17.93
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2020
349 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q2 2020.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 291 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111,608,181 shares
.
Largest 10 shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (16,195,310 shares), PAULSON & CO. INC. (11,486,905 shares), Adelphi Capital LLP (9,156,315 shares), RENAISSANCE TECHNOLOGIES LLC (5,607,700 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,495,336 shares), VANGUARD GROUP INC (4,538,071 shares), MACQUARIE GROUP LTD (4,195,081 shares), NORTHERN TRUST CORP (3,816,937 shares), Parametric Portfolio Associates LLC (3,494,212 shares), and GMT CAPITAL CORP (3,361,876 shares).
This table shows the top 291 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.